Very early alloantigen-independent trafficking of lymphocytes during ischemic acute kidney injury

Kidney International

Volumn 71, Issue 12, 2007, Pages 1193-1195

  Gandolfo, M T ^a   Rabb, H ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; EARLY ANTIGEN; FINGOLIMOD; MESSENGER RNA; SEW 2871; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; B LYMPHOCYTE; BRADYCARDIA; CELLULAR IMMUNITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY GRAFT REJECTION; LYMPHOCYTE ACTIVATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL PROTECTION; RETINA MACULA EDEMA; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 34250001707     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002285     Document Type: Note

References (13)

1. Rabb H, Daniels F, O'Donnell M et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 2000; 279: F525-F531.
2. Burne MJ, Daniels F, El Ghandour A et al. Identification of the CD4 (+) T cell as a major pathogenic factor in ischemic acute renal failure. J Clin Invest 2001; 108: 1283-1290.
3. De Greef KE, Ysebaert DK, Dauwe S et al. Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 2001; 60: 1415-1427.
4. Day YJ, Huang L, Ye H et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 2006; 176: 3108-3114.
5. Ascon DB, Lopez-Briones S, Liu M et al. Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 2006; 117: 3380-3387.
6. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine 1979; 58: 362-376.
7. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004; 66: 486-491.
8. Goggins WC, Pascual MA, Powelson JA et al. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798-802.
9. Awad AS, Ye H, Huang L et al. Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 2006; 290: F1516-F1524.
10. Budde K, Schutz M, Glander P et al. FTY720 (fingolimod) in renal transplantation. Clin Transplant 2006; 20(Suppl 17): 17-24.
11. Lai L-W, Yong K-C, Igarashi S, Y-H Lien. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int 2007; 71: 1223-1231.
12. Ishikawa Y, Akasaka Y, Kiguchi H et al. The human renal lymphatics under normal and pathological conditions. Histopathology 2006; 49: 265-273.
13. Oliver JA, Maarouf O, Cheema FH et al. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004; 114: 795-804.